Jaime F. Cardenas-Navia

Jaime F. Cardenas-Navia


Associate, New York

Jaime has extensive experience with patent infringement disputes and has litigated multiple cases through trial.  He has worked on matters involving a variety of consumer and commercial products, including smartphones, tablets, cameras, printers, nutritional formulations, and solar panels. 

During law school, Jaime interned at the Court of Appeals for the Federal Circuit in the chambers of Judge Jimmie V. Reyna, and at the International Trade Commission in the Office of General Counsel.  Prior to law school, he worked as an Examiner at the U.S. Patent and Trademark Office, where he examined Business Methods patent applications.

Publications

Jaime F. Cardenas-Navia, Thirty Years of Flawed Incentives: an Empirical and Economic Analysis of Hatch-Waxman Patent-Term Restoration, 29 Berkeley Tech. L.J. (2015).  
Available at: http://scholarship.law.berkeley.edu/btlj/vol29/iss2/6.  

Case Highlight
Jaime was on the team that defended Canon in a half-decade dispute with Intellectual Ventures encompassing four lawsuits, five inter partes reviews, and more than twenty patents. He was involved in all aspects of the case, including as part of two trial teams, before the parties ultimately reach a settlement.
Representative Matters
  • Representing Koninklijke Philips N.V. against major smartphone, tablet, and computer companies in patent infringement disputes involving technologies such as touchscreens, graphical user interfaces, audio and video standards, and digital rights management. 
  • Defending Canon, Inc. against Intellectual Ventures, Inc. in multiple patent infringement disputes involving various aspects of printer, scanner, camera and Wi-Fi technologies.
  • Representing E.I. du Pont de Nemours & Co. against SunEdison, Inc. in a patent infringement dispute involving an efficiency-improving paste used in the manufacture of solar panels.
  • Representing Bausch & Lomb, Inc. & Wyeth LLC against Vitamin Health, Inc. in a patent infringement dispute involving a vitamin formulation that prevents the onset of advanced age-related macular degeneration.